Loading...
•
Dec 31, 2019
Quest Diagnostics Q4 2019 Earnings Report
Reported record fourth quarter revenues and earnings, provided guidance for full year 2020, and increased dividend.
Key Takeaways
Quest Diagnostics reported record fourth quarter revenues of $1.93 billion, up 4.8% versus 2018. Diluted earnings per share from continuing operations was $1.86, up 101.2% from 2018, and adjusted diluted EPS was $1.67, up 23.7% from 2018.
Record fourth quarter revenues of $1.93 billion, up 4.8% versus 2018
Record fourth quarter diluted earnings per share from continuing operations ("EPS") of $1.86, up 101.2% from 2018 primarily due to a gain associated with the sale and leaseback of a property
Record adjusted diluted EPS of $1.67, up 23.7% from 2018
Board of Directors authorized a 5.7% increase in its quarterly dividend from $0.53 to $0.56 per share
Quest Diagnostics
Quest Diagnostics
Forward Guidance
The company estimates full year 2020 results as follows: Net revenues $7.80 billion - $7.96 billion. Reported diluted EPS Greater than $5.51. Adjusted diluted EPS Greater than $6.60. Cash provided by operations $1.25 billion - $1.30 billion. Capital expenditures $375 million - $400 million.
Positive Outlook
- Net revenues $7.80 billion - $7.96 billion
- Net revenues increase 1.0% - 3.0%
- Reported diluted EPS Greater than $5.51
- Adjusted diluted EPS Greater than $6.60
- Cash provided by operations $1.25 billion - $1.30 billion
Challenges Ahead
- Capital expenditures $375 million - $400 million